Neurotech International Limited (NTI)

Overview

Neurotech International Limited, established in 2016 and headquartered in Nedlands, Australia, operates within the medical devices sector, focusing its efforts on research, design, development, and manufacturing. The company specializes in creating innovative solutions and conducting medical research. Neurotech International is committed to advancing the Mente platform, a cutting-edge technology aimed at revolutionizing home-based therapies. This commitment underscores the company's dedication to improving patient care through technology.

Products and Services

Neurotech International's offerings are concentrated around the development and commercialization of specialized medical devices, primarily through its Mente platform. The Mente platform represents a significant advancement in the treatment and management of neurological conditions, making use of the latest developments in neurotechnology. Below are the key products and services offered by the company:

• Mente Autism: A flagship product developed for the diagnosis and treatment of autism. Mente Autism employs a non-invasive approach to aid in the therapy of autism spectrum disorders, utilizing neurofeedback technology to create personalized auditory stimulation designed to encourage positive brain function.
• Medical Research Projects: Neurotech International is actively engaged in the execution of medical research projects. These projects aim at exploring new frontiers in medical technology and developing innovative devices that can cater to the vast needs of the healthcare sector.
• Technological Device Development: The company is involved in the ongoing development of technological devices, which are integral to the delivery of its medical solutions. This includes continuous improvement of the Mente platform and exploring additional applications of the technology in other areas of health care.